Our results are comparable to those of a study on the disclosure of APOE genotypes to adult children of patients with Alzheimer disease (AD) that measured symptoms of anxiety, depression and test-related distress (Green et al. REVEAL study, 2009). This evidence concerns the gene APOE and depressive symptom measurement.